(De)randomized Construction of Small Sample Spaces in NC
✍ Scribed by David R. Karger; Daphne Koller
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 384 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0022-0000
No coin nor oath required. For personal study only.
✦ Synopsis
Koller and Megiddo introduced the paradigm of constructing compact distributions that satisfy a given set of constraints and showed how it can be used to efficiently derandomize certain types of algorithms. In this paper, we significantly extend their results in two ways. First, we show how their approach can be applied to deal with more general expectation constraints. More importantly, we provide the first parallel (NC) algorithm for constructing a compact distribution that satisfies the constraints up to a small relative error. This algorithm deals with constraints over any event that can be verified by finite automata, including all independence constraints as well as constraints over events relating to the parity or sum of a certain set of variables. Our construction relies on a new and independently interesting parallel algorithm for converting a solution to a linear system into an almost basic approximate solution to the same system. We use these techniques in the first NC derandomization of an algorithm for constructing large independent sets in d-uniform hypergraphs for arbitrary d. We also show how the linear programming perspective suggests new proof techniques which might be useful in general probabilistic analysis.
📜 SIMILAR VOLUMES
Background. Preclinical data suggested that alphainterferon (IFN) may potentiate chemotherapy cytotoxicity. Methods. A prospective multicentric randomized trial was initiated to assess the clinical benefit of adding This work was conducted by the Italian Lung Cancer Task Force (FONICAP), which carr
## Abstract ## BACKGROUND Preclinical and clinical evidence suggests that a fixed infusion rate of 10 mg/m^2^ per minute may be more effective than the standard 30‐minute infusion of gemcitabine. To investigate the activity and toxicity of the cisplatin plus gemcitabine combination with gemcitabin
## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun